Heart Failure in Patients with Diabetes Mellitus
Key result
Intensive glucose lowering in patients with diabetes does not significantly reduce cardiovascular risk but results in a significant increase in heart failure risk.
Population
Patients with comorbid diabetes mellitus and heart failure
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Antidiabetic agents may raise HF hospitalization and mortality risks; leaves open safer strategies for comorbid patients pending higher-level trials.
Structured PICO
P
Population
Patients with comorbid diabetes mellitus and heart failure
I
Intervention
Antidiabetic medications and intensive glucose lowering
Heart failure should be prioritized in patients with comorbid diabetes, and the choice of glucose-lowering agents must be carefully managed by the heart failure team due to varying risk-benefit ratios.
Limitations
- No specific randomised clinical trials have been conducted to test the effect of cardiovascular drugs in diabetic patients with heart failure.
- The optimal target level of glycated haemoglobin remains unresolved.
Cite This Study
Rosano et al. (2017) conducted a review in Diabetes Mellitus and Heart Failure. Intensive glucose lowering vs. Standard glycemic control was evaluated. Intensive glucose lowering in patients with diabetes does not significantly reduce cardiovascular risk but results in a significant increase in heart failure risk.